GlassScriptPhysician profile
John D Schulte
NPI 1487276580
$1,402.87
in general payments reported to CMS, 2019-2025
22 companies · $793 in 2025
The $793 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.22 · 2022: $113 · 2023: $316 · 2024: $123 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $726 · Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $725.90 |
| Food and Beverage | $505.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $792.57 | 2025 | Mako |
| Depuy Synthes Sales INC. | $78.96 | 2022-2024 | Orthovisc, Monovisc |
| Medacta USA, INC. | $59.00 | 2023 | Gmk Sphere |
| Biotissue Holdings INC. | $57.32 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $44.38 | 2022-2023 | Euflexxa |
| Boston Scientific Corporation | $41.04 | 2023 | Wavewriter Alpha Prime 16 |
| Anika Therapeutics, INC. | $38.85 | 2024 | Sports Medicine, X-Twist, Integrity |
| Kowa Pharmaceuticals America, INC. | $27.78 | 2023 | Seglentis |
| Treace Medical Concepts, INC. | $27.00 | 2024 | |
| Zimmer Biomet Holdings, INC. | $24.97 | 2021 | |
| Sanofi-Aventis U.S. LLC | $21.33 | 2023 | |
| Intrinsic Therapeutics | $20.95 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $20.81 | 2023 | |
| Convatec INC. | $19.72 | 2021 | |
| Si-Bone, INC. | $19.49 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $18.79 | 2023 | Durolane |
| Electronic Waveform Lab, INC. | $17.17 | 2023 | |
| Davol INC. | $15.36 | 2023 | |
| Heron Therapeutics, INC. | $14.53 | 2021 | |
| Kuros Biosciences USA, INC | $14.40 | 2022 | |
| Smith+Nephew, INC. | $14.30 | 2023 | Stravix |
| Curonix LLC | $14.15 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schulte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.